Literature DB >> 11156605

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

B Elenbaas1, L Spirio, F Koerner, M D Fleming, D B Zimonjic, J L Donaher, N C Popescu, W C Hahn, R A Weinberg.   

Abstract

A number of genetic mutations have been identified in human breast cancers, yet the specific combinations of mutations required in concert to form breast carcinoma cells remain unknown. One approach to identifying the genetic and biochemical alterations required for this process involves the transformation of primary human mammary epithelial cells (HMECs) to carcinoma cells through the introduction of specific genes. Here we show that introduction of three genes encoding the SV40 large-T antigen, the telomerase catalytic subunit, and an H-Ras oncoprotein into primary HMECs results in cells that form tumors when transplanted subcutaneously or into the mammary glands of immunocompromised mice. The tumorigenicity of these transformed cells was dependent on the level of ras oncogene expression. Interestingly, transformation of HMECs but not two other human cell types was associated with amplifications of the c-myc oncogene, which occurred during the in vitro growth of the cells. Tumors derived from the transformed HMECs were poorly differentiated carcinomas that infiltrated through adjacent tissue. When these cells were injected subcutaneously, tumors formed in only half of the injections and with an average latency of 7.5 weeks. Mixing the epithelial tumor cells with Matrigel or primary human mammary fibroblasts substantially increased the efficiency of tumor formation and decreased the latency of tumor formation, demonstrating a significant influence of the stromal microenvironment on tumorigenicity. Thus, these observations establish an experimental system for elucidating both the genetic and cell biological requirements for the development of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156605      PMCID: PMC312602          DOI: 10.1101/gad.828901

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  50 in total

1.  Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells.

Authors:  M H Barcellos-Hoff; S A Ravani
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

2.  Risky immortalization by telomerase.

Authors:  J Wang; G J Hannon; D H Beach
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

3.  Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin.

Authors:  M L Rodriguez-Puebla; M LaCava; M F Bolontrade; J Russell; C J Conti
Journal:  Mol Carcinog       Date:  1999-11       Impact factor: 4.784

4.  Profile of genetic alterations and tumorigenicity of human breast cancer cells.

Authors:  D B Zimonjic; C L Keck-Waggoner; B Z Yuan; M H Kraus; N C Popescu
Journal:  Int J Oncol       Date:  2000-02       Impact factor: 5.650

5.  Multicolor spectral karyotyping of human chromosomes.

Authors:  E Schröck; S du Manoir; T Veldman; B Schoell; J Wienberg; M A Ferguson-Smith; Y Ning; D H Ledbetter; I Bar-Am; D Soenksen; Y Garini; T Ried
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

6.  Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells.

Authors:  S A Foster; D A Galloway
Journal:  Oncogene       Date:  1996-04-18       Impact factor: 9.867

Review 7.  The loss of estrogen and progesterone receptor gene expression in human breast cancer.

Authors:  R G Lapidus; S J Nass; N E Davidson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 8.  Human breast cancer cell lines as models of growth regulation and disease progression.

Authors:  S P Ethier
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

9.  Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping.

Authors:  S Kytölä; J Rummukainen; A Nordgren; R Karhu; F Farnebo; J Isola; C Larsson
Journal:  Genes Chromosomes Cancer       Date:  2000-07       Impact factor: 5.006

10.  Preferential growth of mammary tumors in intact mammary fatpads.

Authors:  F R Miller; D Medina; G H Heppner
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

View more
  415 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement.

Authors:  Rebecca A Whipple; Michael A Matrone; Edward H Cho; Eric M Balzer; Michele I Vitolo; Jennifer R Yoon; Olga B Ioffe; Kimberly C Tuttle; Jing Yang; Stuart S Martin
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

3.  Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.

Authors:  Gouri Chatterjee; Andrea Rosner; Yi Han; Edward T Zelazny; Baolin Li; Robert D Cardiff; Archibald S Perkins
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.

Authors:  Hao Liu; Christina Tekle; Yih-Wen Chen; Alexandr Kristian; Yuhua Zhao; Ming Zhou; Zixing Liu; Yan Ding; Bin Wang; Gunhild Mari Mælandsmo; Jahn Marthin Nesland; Oystein Fodstad; Ming Tan
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

5.  Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.

Authors:  Sheila A Stewart; William C Hahn; Benjamin F O'Connor; Elisa N Banner; Ante S Lundberg; Poonam Modha; Hana Mizuno; Mary W Brooks; Mark Fleming; Drazen B Zimonjic; Nicholas C Popescu; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

Review 6.  Modeling tissue-specific signaling and organ function in three dimensions.

Authors:  Karen L Schmeichel; Mina J Bissell
Journal:  J Cell Sci       Date:  2003-06-15       Impact factor: 5.285

7.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.

Authors:  Hengyu Lu; Nicole Villafane; Turgut Dogruluk; Caitlin L Grzeskowiak; Kathleen Kong; Yiu Huen Tsang; Oksana Zagorodna; Angeliki Pantazi; Lixing Yang; Nicholas J Neill; Young Won Kim; Chad J Creighton; Roel G Verhaak; Gordon B Mills; Peter J Park; Raju Kucherlapati; Kenneth L Scott
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

9.  IRP2 regulates breast tumor growth.

Authors:  Wei Wang; Zhiyong Deng; Heather Hatcher; Lance D Miller; Xiumin Di; Lia Tesfay; Guangchao Sui; Ralph B D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

10.  Role of connexins in metastatic breast cancer and melanoma brain colonization.

Authors:  Konstantin Stoletov; Jan Strnadel; Erin Zardouzian; Masashi Momiyama; Frederick D Park; Jonathan A Kelber; Donald P Pizzo; Robert Hoffman; Scott R VandenBerg; Richard L Klemke
Journal:  J Cell Sci       Date:  2013-01-15       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.